Intracerebral hemorrhage (ICH) is associated with poor outcome,
|
|
- Melinda Page
- 6 years ago
- Views:
Transcription
1 Low Serum Calcium Levels Contribute to Larger Hematoma Volume in Acute Intracerebral Hemorrhage Yasuteru Inoue, MD; Fumio Miyashita, MD; Kazunori Toyoda, MD; Kazuo Minematsu, MD Downloaded from by guest on April 9, 2018 Background and Purpose We investigate whether admission serum calcium levels are associated with hematoma volume, stroke severity, and outcomes in patients with acute intracerebral hemorrhage. Methods A total of 273 patients admitted within 24 hours after intracerebral hemorrhage onset was divided into quartiles based on admission serum calcium levels (Q1 [ 9.0], Q2 [ ], Q3 [ ], Q4 [ 9.8] mg/dl). Results Median hematoma volumes for each quartile (Q1 to Q4) were 18, 9, 10, and 9 ml (P=0.005), and median National Institutes of Health Stroke Scale scores were 16, 11, 11, and 9 (P=0.010), respectively. On multivariate analysis, Q1 had larger hematoma volume (P=0.025) and higher National Institutes of Health Stroke Scale score (P=0.020) than Q4. There were fewer patients with modified Rankin Scale scores 0 to 2 in Q1 than Q4 after adjustment for risk factors and comorbidities (odds ratio, 0.31; 95% confidence interval, ) but not after additional adjustment for hematoma volume and National Institutes of Health Stroke Scale score. There were more patients with modified Rankin Scale scores 5 to 6 (P=0.016) and with fatal outcomes (P=0.048) in Q1 than Q4 as crude values, but not after adjustment. Conclusions Low admission serum calcium levels were associated with larger hematoma volume and higher National Institutes of Health Stroke Scale score among patients with acute intracerebral hemorrhage. (Stroke. 2013;44: ) Key Words: acute stroke hematoma intracerebral hemorrhage serum calcium stroke outcome Intracerebral hemorrhage (ICH) is associated with poor outcome, a high mortality rate, and little effective treatment. 1 In patients with acute ICH, large hematoma volume, the presence of intraventricular bleeding, and prior use of anticoagulants or antiplatelets are reported to be associated with poor outcome. 2,3 Several studies have reported that low serum calcium (Ca) levels have an association with large infarcts and poor outcome among patients with ischemic stroke. 4 6 In another study involving a majority of patients with ischemic stroke and few patients with ICH, low serum Ca levels were also associated with poor outcome. 7 In addition, ionized Ca is an essential cofactor for the coagulation cascade and associated with conversion of prothrombin to thrombin. Association of Ca levels with changes in clotting time and bleeding tendency was shown in the rodent models. 8,9 Thus, serum Ca levels might play a pivotal role in hemostasis in acute ICH. However, associations of serum Ca levels with clinical findings and outcomes of isolated patients with ICH remain unknown. Thus, the aim of the present study was to examine the associations between admission Ca levels and clinical findings and outcomes in patients with acute ICH. Patients and Methods Consecutive patients admitted to our department within 24 hours from the onset of nontraumatic ICH were studied using our prospectively collected database on inpatients with stroke. Patients were classified into quartiles based on admission serum Ca levels (Q1 [ 9.0], Q2 [ ], Q3 [ ], Q4 [ 9.8] mg/dl). Acute outcomes included the following: the National Institutes of Health Stroke Scale (NIHSS) score at admission, initial hematoma volume, and hematoma growth. Chronic outcomes included the following: modified Rankin Scale (mrs) scores of 0 to 1 and 0 to 2, bedridden state or death corresponding to mrs scores of 5 to 6 at 30 days, and mortality. For chronic outcomes, patients with prestroke mrs score 2 were excluded from the analyses. Associations between each Ca quartile and outcomes were determined using multivariate regression models adjusted by the baseline characteristics automatically selected in a backward stepwise selection method (see Methods in the online-only Data Supplement). Results A total of 273 patients (92 women, 70±11 years old) were studied. There were fewer women (P=0.036), liver dysfunction was more common (P=0.043), and levels of albumin (P<0.001), total cholesterol (P=0.002), low-density lipoprotein cholesterol (P<0.001), high-density lipoprotein cholesterol (P=0.027), and hemoglobin (P=0.002) were lower in the lower Ca level quartiles than in the higher Ca level quartiles (see Tables I and II in the online-only Data Supplement). The lowest Ca quartile had higher hematoma volume (P=0.005; Table 1). After multivariate linear regression analyses, Q1 had larger hematoma volume than Q4 (P=0.015). The lowest Ca quartile had a higher NIHSS score (P=0.010). Received February 13, 2013; accepted March 26, From the Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. The online-only Data Supplement is available with this article at /-/DC1. Correspondence to Kazunori Toyoda, MD, Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Fujishiro-dai, Suita, Osaka , Japan. toyoda@hsp.ncvc.go.jp 2013 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA
2 Inoue et al Serum Calcium, Hematoma Volume, and Severity in ICH 2005 Table 1. Multivariate Analysis for Hematoma Volume and NIHSS Score Downloaded from by guest on April 9, 2018 Figure. Distribution of the modified Rankin Scale (mrs) score at 30 days. After multivariate linear regression analyses, Q1 had a higher NIHSS score than Q4 (P=0.010). The Figure shows the distribution of mrs scores. No patients in Q1 had mrs score 0 to 1, as compared with other quartiles (P<0.001). Patients with mrs score 0 to 2 were less frequent in Q1 than Q4 as crude values (P=0.002) and after adjustment with risk factors and comorbidities (P=0.026), but they were no longer different after additional adjustment with hematoma volume and NIHSS score (Table 2). Patients with mrs score 5 to 6 and those with fatal outcomes were more frequent in Q1 than Q4 as crude values (P=0.016 and 0.048, respectively), but the difference disappeared after multivariate adjustment (Table III in the online-only Data Supplement). Discussion This is the first study that investigated the relationships between serum Ca levels at admission and clinical findings and outcomes of patients with acute ICH. The major new finding was that patients with low Ca levels had larger hematoma volumes and higher NIHSS scores at admission. Three possible mechanisms may explain why serum Ca levels are related to severity at admission. First, as stated above, ionized Ca is an essential cofactor for the coagulation cascade. Second, low serum Ca levels might contribute to hematoma Median Value (Interquartile Ratio) β SE P value Hematoma volume* Q1 18 (9 40) Q2 9 (4 30) Q3 10 (4 18) Q4 9 (2 22) 0 (reference) NIHSS score Q1 16 (9 22) Q2 11 (6 18) Q3 11 (7 16) Q4 9 (5 17) 0 (reference) β: Difference in log-transformed values compared with Q4. NIHSS indicates National Institutes of Health Stroke Scale. *Adjusted by age, sex, history of stroke, anticoagulant, antiplatelet and statin use, onset-arrival time, intraventricular bleeding, hemoglobin, and prothrombin time-international normalized ratio in a backward stepwise selection method. Adjusted by age, sex, anticoagulant, antihypertensive and statin use, onsetarrival time, intraventricular bleeding, phosphorus, aspartate transaminase, glucose, and prothrombin time-international normalized ratio in a backward stepwise selection method. enlargement through blood pressure elevation in the acute ICH. Ca was reported to induce relaxation of isolated arteries by activating Ca receptors in perivascular nerves. 10 Third, low serum Ca levels might reflect poor liver function. The lowest Ca quartile (Q1) had high percentage of liver disease, and these findings suggested another mechanism for poor coagulation and therefore larger hematoma volume. This study was limited by its design as a single-center, hospital-based, retrospective analysis with exclusion of some patients attributable to lack of serum Ca level data. To simplify reporting of results, data on ionized Ca levels and albumin-corrected Ca levels were not shown. Instead, the serum albumin level was used for multivariate regression analyses and it did not affect the results. In conclusion, low Ca levels in the hyperacute stage of ICH are indicators of larger hematoma volume and more severe neurological deficit. There is an apparent association between serum Ca levels and hematoma volume. Future studies could incorporate serum Ca in models and test for enhanced Table 2. Multivariate Analysis for Modified Rankin Scale Score 0 to 2 at 30 Days Patients, % Crude Adjusted: Model 1 Adjusted: Model 2 OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value Q1 8 (14.0) 0.25 ( ) ( ) ( ) Q2 28 (37.3) 0.91 ( ) ( ) ( ) Q3 21 (31.8) 0.71 ( ) ( ) ( ) Q4 23 (39.7) 1 (reference) 1 (reference) 1 (reference) Patients with prestroke modified Rankin Scale score 2 were excluded from the analyses. CI indicates confidence interval; and OR, odds ratio. Model 1: Adjusted by age, sex, anticoagulant and statin use, onset-arrival time, intraventricular bleeding, blood glucose, and prothrombin time-international normalized ratio. Model 2: Further adjusted by National Institutes of Health Stroke Scale score and hematoma volume.
3 2006 Stroke July 2013 Downloaded from by guest on April 9, 2018 predictive power over existing models. The clinical benefit and therapeutic time window for Ca level modification, as well as the Ca threshold level that is beneficial for ICH prevention, remain unknown, and further investigations of these issues will be required. Sources of Funding This study was supported in part by grants-in-aid (H23-Junkanki- Ippan-010, H24-Junkanki-Ippan-011) from the Ministry of Health, Labor and Welfare, Japan, and the Intramural Research Fund for Cardiovascular Diseases from the National Cerebral and Cardiovascular Center (H22-4-1, H23-4-3). None. Disclosures References 1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344: Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24: Toyoda K, Yasaka M, Nagata K, Nagao T, Gotoh J, Sakamoto T, et al. Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study. Cerebrovasc Dis. 2009; 27: Ovbiagele B, Liebeskind DS, Starkman S, Sanossian N, Kim D, Razinia T, et al. Are elevated admission calcium levels associated with better outcomes after ischemic stroke? Neurology. 2006;67: Buck BH, Liebeskind DS, Saver JL, Bang OY, Starkman S, Ali LK, et al. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol. 2007;64: Ovbiagele B, Starkman S, Teal P, Lyden P, Kaste M, Davis SM, et al; VISTA Investigators. Serum calcium as prognosticator in ischemic stroke. Stroke. 2008;39: Appel SA, Molshatzki N, Schwammenthal Y, Merzeliak O, Toashi M, Sela BA, et al. Serum calcium levels and long-term mortality in patients with acute stroke. Cerebrovasc Dis. 2011;31: Fukuda T, Nakashima Y, Harada M, Toyoshima S, Koshitani O, Kawaguchi Y, et al. Effect of whole blood clotting time in rats with ionized hypocalcemia induced by rapid intravenous citrate infusion. J Toxicol Sci. 2006;31: Fujita Y, Doi K, Harada D, Kamikawa S. Modulation of physiological hemostasis by irrigation solution: comparison of various irrigation solutions using a mouse brain surface bleeding model. J Neurosurg. 2010;112: Bukoski RD, Bian K, Wang Y, Mupanomunda M. Perivascular sensory nerve Ca2+ receptor and Ca2+-induced relaxation of isolated arteries. Hypertension. 1997;30:
4 Low Serum Calcium Levels Contribute to Larger Hematoma Volume in Acute Intracerebral Hemorrhage Yasuteru Inoue, Fumio Miyashita, Kazunori Toyoda and Kazuo Minematsu Downloaded from by guest on April 9, 2018 Stroke. 2013;44: ; originally published online May 14, 2013; doi: /STROKEAHA Stroke is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX Copyright 2013 American Heart Association, Inc. All rights reserved. Print ISSN: Online ISSN: The online version of this article, along with updated information and services, is located on the World Wide Web at: Data Supplement (unedited) at: Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Stroke can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: Subscriptions: Information about subscribing to Stroke is online at:
5 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p1 ONLINE SUPPLEMENT Low serum calcium levels contribute to larger hematoma volume in acute intracerebral hemorrhage Yasuteru Inoue, et al Supplemental Methods Patients and Methods Consecutive patients admitted to our department within 24 hours from the onset of nontraumatic ICH from January 2004 through June 2009 were studied using our prospectively collected database on stroke inpatients. Patients with ICH in association with vascular malformations, aneurysms, tumors, and impaired coagulation (e.g., disseminated intravascular coagulation syndrome) and those with primary intraventricular hemorrhage were excluded from the study. Thus, 383 patients were enrolled. Of these, one with poor imaging data and 109 with unavailable admission serum Ca data were excluded. Finally, 273 patients (92 women, 70±11 years old) were studied. The baseline characteristics of the 273 patients and the 110 excluded patients were similar, except for a history of liver dysfunction (10.6% vs. 3.7%; p=0.029) and time from ICH onset to arrival (median 145 min vs.110 min; p=0.029). The ethics committee approved this study. CT imaging and image analysis ICH was verified by emergent computed tomography (CT) immediately after hospital arrival. Follow-up CT was performed routinely within 24 hours after admission. Hematoma location and the presence of intraventricular bleeding were recorded on initial CT scan. Hematoma volumes were measured using the ABC/2 method. 1 Intraventricular bleeding was not included in volume calculations. All CT scans were reviewed and evaluated by two trained stroke specialists who were blinded to the patients clinical status. Data collection Baseline clinical and demographic information included age, sex, history of ischemic stroke or prior ICHs, premorbid modified Rankin Scale (mrs) score, liver dysfunction 1
6 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p2 (cirrhosis or chronic hepatitis on history), hypertension, diabetes mellitus, dyslipidemia, history of alcohol or tobacco use, and prestroke use of anticoagulants, antiplatelet agents, antihypertensive agents, and statins. Body mass index and blood pressure (BP) levels on admission were also documented. The time of ICH onset was defined as the time when the patient was last known to be normal if the exact time of acute onset of a neurological deficit could not be clearly specified. Blood tests were performed at the time of admission before any crystalloid infusion therapy. Laboratory results, including Ca and the variables listed in Table 2, were recorded, and the estimated glomerular filtration rate (egfr) was calculated. 2 Enzymatic measurement of baseline serum Ca levels was performed at a central laboratory with a Hitachi Modular Analytics analyzer (normal range: mg/dl). Patients were divided into quartiles by their Ca levels. Outcomes As acute outcome measures, the National Institutes of Health Stroke Scale (NIHSS) score on admission evaluated by stroke experts, initial hematoma volume, and hematoma growth were assessed. Chronic outcomes were evaluated at 30 days; independence corresponding to mrs scores of 0-1 and 0-2, bedridden state or death corresponding to mrs scores of 5-6, and mortality were assessed. For chronic outcomes, 18 patients with prestroke mrs score 2 were excluded from the analyses. Statistical analysis Baseline demographics and clinical characteristics were compared across quartiles by serum Ca levels using the χ 2 test for percentages and the Kruskal-Wallis rank-sum test for medians. Continuous variables are reported as medians (interquartile range) unless stated otherwise. Fisher s exact test was used to compare dichotomous variables between groups, and the Wilcoxon rank-sum test was used for continuous and ordinal variables. The difference in each quartile of serum Ca levels compared to the highest quartile of Ca levels (Q4) was measured in relation to hematoma volume, NIHSS score on admission, and outcomes. Hematoma volume and NIHSS score on admission were log-transformed to approximate 2
7 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p3 normality. Multivariate linear regression analyses for hematoma volume and NIHSS score on admission and multivariate logistic regression analyses for 30-day outcomes were performed by adjusting for sex, age, and variables that were automatically selected in a backward stepwise selection method. A backward selection procedure was performed for each outcome using p>0.10 of the likelihood ratio test for exclusion. The odds ratio and 95% CI were obtained. Statistical significance was set at p<0.05. Statistical analysis was performed using the JMP 8.0 statistical software (SAS Institute Inc, Cary, NC). Supplemental references 1. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996; 27: Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53:
8 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p4 Supplemental tables Table S1. Baseline clinical characteristics according to serum calcium level quartiles Total Q1 Q2 Q3 Q4 Number of patients Age, years 70±11 71±11 69±11 68±11 70±11 Women 92 (33.7) * 17 (27.4) 20 (26.0) 25 (35.2) 30 (47.6) Comorbidities Past history of stroke 57 (20.9) 19 (30.6) 15 (19.5) 9 (12.7) 14 (22.2) Liver dysfunction 29 (10.6) * 12 (19.4) 9 (11.7) 4 (5.6) 4 (6.3) Prestroke mrs score 2 18 (6.6) 8 (12.9) 3 (3.9) 2 (2.8) 5 (7.9) Risk factors Hypertension 246 (90.1) 53 (85.5) 71 (92.2) 62 (87.3) 60 (95.2) Diabetes mellitus 63 (23.1) 14 (22.6) 19 (24.7) 14 (19.7) 16 (25.4) Dyslipidemia 63 (23.1) 14 (22.6) 19 (24.7) 14 (19.7) 16 (25.4) Alcohol consumption 152 (55.7) 37 (59.7) 49 (63.6) 36 (50.7) 30 (47.6) Smoking habit 67 (24.5) 21 (33.9) 16 (20.8) 13 (18.3) 17 (27.0) Prestroke medications Anticoagulants 22 (8.1) 6 (9.7) 5 (6.5) 5 (7.0) 6 (9.5) Antiplatelets 49 (17.9) 13 (21.0) 15 (19.5) 7 (9.9) 14 (22.2) Antihypertensives 128 (46.9) 29 (46.8) 33 (42.9) 35 (49.3) 31 (49.2) Statins 28 (10.3) 9 (14.5) 7 (9.1) 6 (8.5) 6 (9.5) Data are presented as means±sd for age and numbers of patients with percentages in parentheses for the others. * p<0.05 among quartiles. 4
9 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p5 Table S2. ICH features and data on admission according to serum calcium level quartiles Total Q1 Q2 Q3 Q4 Number of patients ICH features Time from ICH onset to arrival, min 145 (70-493) 120 (67-473) 145 (60-601) 180 (75-390) 200 (80-600) Intraventricular bleeding 99 (36.3) 31 (50.0) 23 (29.9) 23 (32.4) 22 (34.9) Location of hematoma Thalamo-ganglionic 193 (70.7) 41 (66.1) 50 (64.9) 55 (77.5) 47 (74.6) Lobar 44 (16.1) 12 (19.4) 17 (22.1) 8 (11.3) 7 (11.1) Cerebellar 10 (3.7) 2 (3.2) 3 (3.9) 2 (2.8) 3 (4.8) Brain stem 26 (9.5) 7 (11.3) 7 (9.1) 6 (8.5) 6 (9.5) Physiological data on admission Body mass index 22.4± ± ± ± ±3.8 Systolic blood pressure, mmhg 179.0± ± ± ± ±27.9 Diastolic blood pressure, mmhg 94.4± ± ± ± ±19.2 Blood test results on admission Calcium, mg/dl 9.4±0.49 * 8.8± ± ± ±0.39 Albumin, mg/dl 4.1±0.40 * 3.8± ± ± ±0.35 Total cholesterol, mg/dl 192±39 * 176±43 190±32 193±35 206±44 LDL-Cho, mg/dl 112±35 * 96±35 113±32 114±31 123±38 Triglycerides, mg/dl 119±77 127±86 113±71 122±86 116±63 HDL-Cho, mg/dl 56±17 * 52±20 55±15 55±16 60±18 Phosphorus, mg/dl 3.0± ± ± ± ±0.84 Blood urea nitrogen, mg/dl 18.4± ± ± ± ±16.7 Creatinine, mg/dl 1.1± ± ± ± ±2.27 Aspartate transaminase, IU/L 36.5± ± ± ± ±39.6 Alanine aminotransferase, IU/L 26.1± ± ± ± ±27.6 Blood glucose, mg/dl 142±51 154±75 142±41 136±45 135±38 hs-crp, mg/dl 0.36± ± ± ± ±0.71 Hemoglobin, g/dl 13.8±1.9 * 13.0± ± ± ±2.0 Platelet count, 10 4 /μl 22.0± ± ± ± ±6.1 aptt, s 28.3± ± ± ± ±4.1 PT-INR 1.04± ± ± ± ±0.33 egfr, ml/min 76.4± ± ± ± ±28.3 Length of hospital stay (days) 26 (17-38) 30 (19-39) 26 (17-39) 25 (19-37) 25 (14-39) 5
10 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p6 Data are presented as means±sd for continuous variables, medians with interquartile ranges in parentheses for discontinuous variables, and numbers of patients with percentages in parentheses for the others. * p<0.05 among quartiles. Data on total cholesterol and aptt are missing in 1 patient, those on triglycerides in 4, LDL-Cho in 6, HDL-Cho in 20, and phosphorus in 28. Abbreviation: LDL-Cho, low-density-lipoprotein cholesterol; HDL-Cho, high-density-lipoprotein cholesterol; hs-crp, high sensitive C-reactive protein; aptt, activated partial thromboplastin time; PT-INR, prothrombin time-international normalized ratio; e-gfr, estimated glomerular filtration rate 6
11 Inoue et al: Serum Calcium, hematoma volume and severity in ICH, p7 Table S3. Multivariate analysis for outcomes at 30 days Patients (%) Crude Adjusted: model 1 Adjusted: model 2 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value Modified Rankin Scale score 5-6 Q1 25 (43.9) 2.70 ( ) ( ) ( ) Q2 16 (21.3) 0.94 ( ) ( ) ( ) Q3 14 (21.2) 0.93 ( ) ( ) ( ) Q4 13 (22.4) 1 (Reference) 1 (Reference) 1 (Reference) Death Q1 10 (17.5) 3.90 ( ) ( ) ( ) Q2 3 (4.0) 0.76 ( ) ( ) ( ) Q3 2 (3.0) 0.57 ( ) ( ) ( ) Q4 3 (5.2) 1 (Reference) 1 (Reference) 1 (Reference) Patients with prestroke mrs score 2 were excluded from the analysis. Model 1: Adjusted by age, sex, prestroke statin use, intraventricular bleeding, aspartate transaminase, and blood glucose in Modified Rankin Scale score 5-6. Adjusted by age, sex, liver dysfunction, prestroke antiplatelet use, systolic blood pressure, albumin, hemoglobin, and platelet count in Death. Model 2: Adjusted by variables in Model 1 plus NIHSS score on admission and hematoma volume. 7
In cerebral infarction, the prognostic value of angiographic
Nonrelevant Cerebral Atherosclerosis is a Strong Prognostic Factor in Acute Cerebral Infarction Jinkwon Kim, MD; Tae-Jin Song, MD; Dongbeom Song, MD; Hye Sun Lee, MS; Chung Mo Nam, PhD; Hyo Suk Nam, MD,
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationBlood pressure (BP) is often elevated after the onset of
Continuous Antihypertensive Therapy Throughout the Initial 24 Hours of Intracerebral Hemorrhage The Stroke Acute Management With Urgent Risk-Factor Assessment and Improvement Intracerebral Hemorrhage Study
More informationJournal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
More informationCharacteristics of Intracerebral Hemorrhage During Rivaroxaban Treatment Comparison With Those During Warfarin
Characteristics of Intracerebral Hemorrhage During Rivaroxaban Treatment Comparison With Those During Warfarin Joji Hagii, MD; Hirofumi Tomita, MD; Norifumi Metoki, MD; Shin Saito, MD; Hiroshi Shiroto,
More informationSubarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2
Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2 Guofang Chen, MD; Hisatomi Arima, MD; Guojun Wu, MD; Emma Heeley, PhD; Candice Delcourt, MD; Peiying Zhang, MD; Alejandro
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationTable 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationRecombinant Factor VIIa for Intracerebral Hemorrhage
Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage
More informationUpdated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข
Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationDefining Severe Familial Hypercholesterolemia. Raul D. Santos MD, PhD Brazil
Defining Severe Familial Hypercholesterolemia Raul D. Santos MD, PhD Brazil 1 Disclosure Honoraria received for consulting, speaker and or researcher activities : Astra Zeneca, Akcea, Amgen, Biolab, Esperion,
More informationThe Effect of Statin Therapy on Risk of Intracranial Hemorrhage
The Effect of Statin Therapy on Risk of Intracranial Hemorrhage JENNIFER HANIFY, PHARM.D. PGY2 CRITICAL CARE RESIDENT UF HEALTH JACKSONVILLE JANUARY 23 RD 2016 Objectives Review benefits of statin therapy
More informationPrimary intracerebral hemorrhage (ICH) is one of the most
ORIGINAL RESEARCH J. Kim A. Smith J.C. Hemphill III W.S. Smith Y. Lu W.P. Dillon M. Wintermark Contrast Extravasation on CT Predicts Mortality in Primary Intracerebral Hemorrhage BACKGROUND AND PURPOSE:
More informationGet With the Guidelines Stroke PMT. Quality Measure Descriptions
Get With the Guidelines Stroke PMT Quality Measure s Last Updated July 2016 Print Measure s Dysphagia Screen Stroke Education Rehabilitation Considered Time to Intravenous Thrombolytic Therapy 60 min LDL
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationA Comparison of Acute Hemorrhagic Stroke Outcomes in 2 Populations The Crete Boston Study
A Comparison of Acute Hemorrhagic Stroke Outcomes in 2 Populations The Crete Boston Study Ioannis Zaganas, MD, PhD; Amy P. Halpin, BS; Alexandra Oleinik, BA; Athanasios Alegakis, PhD; Dimitra Kotzamani,
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationSITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
More informationThai people. Large epidemiology studies in ischemic stroke have shown a modest association of elevated total
Goal achievement of Low-density lipoprotein cholesterol levels in patients with ischemic stroke and hyperlipidemia at Prasat Neurologial lnstitute La-ongsuwan sermsook Introduction Hyperlipidemia is a
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationReview of the TICH-2 Trial
Review of the TICH-2 Trial Mikaela Hofer, PharmD PGY-1 Pharmacy Resident Pharmacy Grand Rounds September 18, 2018 2018 MFMER slide-1 Objectives Review the pharmacologic options to limit hematoma expansion
More informationAcute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban
CASE REPORT Acute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban Yohei Mima 1, Yuhei Sangatsuda 2, Masahiro Yasaka 1, Yoshiyuki Wakugawa 1, Shinji Nagata 2 and Yasushi Okada 1 Abstract
More informationComparison of Spot Sign, Blend Sign and Black Hole Sign for Outcome Prediction in Patients with Intracerebral Hemorrhage
Journal of Stroke 2017;19(3):333-339 Original Article Comparison of Spot Sign, Blend Sign and Black Hole Sign for Outcome Prediction in Patients with Intracerebral Hemorrhage Peter B. Sporns, a Michael
More informationMohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD*
Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Mohamed Al-Khaled,
More informationUse of the Original, Modified, or New Intracerebral Hemorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage
Use of the Original, Modified, or New Intracerebral Hemorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage Raymond Tak Fai Cheung, MBBS, PhD; Liang-Yu Zou, MBBS, MPhil Background
More informationLA CLINICA E LA DIAGNOSI DELLA VERTIGINE VASCOLARE
LA CLINICA E LA DIAGNOSI DELLA VERTIGINE VASCOLARE M. Mandalà Azienda Ospedaliera Universitaria Senese WHY ARE WE SCARED? NEED TO BETTER UNDERSTAND PATHOPHYSIOLOGY WHAT IS KNOWN WHAT IS EFFECTIVE and SIMPLE
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationCorrelation of serum calcium levels with severity and functional outcome in acute ischemic stroke patients
International Journal of Research in Medical Sciences Gupta A et al. Int J Res Med Sci. 2015 Dec;3(12):3698-3702 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151425
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationPrimary Stroke Center Quality & Performance Measures
Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition
More information2013 Hypertension Measure Group Patient Visit Form
Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part
More information2018 Early Management of Acute Ischemic Stroke Guidelines Update
2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital
More informationThe Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment
The Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Adnan I. Qureshi, MD 1, Muhammad A. Saleem, MD 1, Emrah Aytaç, MD
More informationTables of Normal Values (As of February 2005)
Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal
More informationInternational Journal of Pharmacy Teaching & Practices 2012, Vol.3, Issue 1,
Antihypertensive and Increased Intracranial ressure Therapy in atient with Intracerebral Haemorrhage Stroke and Life Expectancy of atients during Hospitalization Luh utu Febryana Larasanty 1, Zullies Ikawati
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationKlinikum Frankfurt Höchst
Blood pressure management in hemorrhagic stroke Blood pressure in acute ICH Do we need additional trials after INTERACT2 and ATTACH-II? Focus.de Department of Neurology,, Germany Department of Neurology,
More informationNew Frontiers in Intracerebral Hemorrhage
New Frontiers in Intracerebral Hemorrhage Ryan Hakimi, DO, MS Director, Neuro ICU Director, Inpatient Neurology Services Greenville Health System Clinical Associate Professor Department of Medicine (Neurology)
More informationPrimary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:
When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation
More informationNew Guidelines in Dyslipidemia Management
The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical
More informationBlood pressure (BP) lowering therapy is widely performed
Systolic Blood Pressure After Intravenous Antihypertensive Treatment and Clinical Outcomes in Hyperacute Intracerebral Hemorrhage The Stroke Acute Management With Urgent Risk-Factor Assessment and Improvement-Intracerebral
More informationEmergency Department Management of Acute Ischemic Stroke
Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,
More informationFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial. Joseph P. Broderick, MD James Grotta, MD Jordan Elm, PhD
FVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial Joseph P. Broderick, MD James Grotta, MD Jordan Elm, PhD Background Intracerebral hemorrhage (ICH) accounts for more than
More informationDownloaded from journal.gums.ac.ir at 3:05 IRST on Sunday February 17th 2019
... (MP h) - (MD) - (MD) * : a_saberi@gums.ac.ir : * 89/2/15 : 88/12/1 : :... 1 72 : 6 67 :. 72 6.. 17 SPSS repeated measure ANOVA nominal regression 1 72. 69/60±13/58 %38/8 %61/20 67 : ( 1).(0/0020/000
More informationBY: Ramon Medina EMT-LP/RN
BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management
More informationThe management of ICH when to operate when not to?
The management of ICH when to operate when not to? Intracranial Hemorrhage High Incidence o Accounts for 10-15% of all strokes 1,2,5 o 80,000 cases in US; 2 million WW 2,5 o Incidence doubles for African-
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationS150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153
S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationSupplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers
Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Medical parameters Cut-off values BMI (kg/m 2 ) 25.0 Waist (cm) (Men and Women) (Men) 85, (Women) 90
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationChapter Two Renal function measures in the adolescent NHANES population
0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you
More informationBlood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.
Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University
More informationThe Multi arm Optimization of Stroke Thrombolysis (MOST) Trial
The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial Study Team Principal Investigators: Opeolu Adeoye, University of Cincinnati (Lead) Andrew Barreto, University of Texas Houston Jim Grotta,
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationCOMPREHENSIVE SUMMARY OF INSTOR REPORTS
COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationyear resident, Department of Medicine, B. J. Medical college, Ahmedabad.
Clinical Study of Type 2 Diabetes Mellitus Patients with or without Cerebrovascular Feature and Its Correlation with Other Comorbidity / Diabetic Complication Vivek Sidhapura 1*, Bipin Amin 2, Amit Potulwar
More informationAnalytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
More informationPerihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage Influence of Hematoma Volume and Location
Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage Influence of Hematoma Volume and Location Santosh B. Murthy, MD, MPH; Yogesh Moradiya, MD; Jesse Dawson, MD; Kennedy R. Lees, MD;
More informationACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club Announcements Next journal club Thursday, Dec. 14 th at 3:00 PM EST PACIFY Trial Effects of IV Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationA n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
More informationIndependent predictors of short-term mortality (30 days)
Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death Pertti Saloheimo, MD; Mikko Ahonen, MD; Seppo Juvela, MD, PhD; Juhani Pyhtinen, MD, PhD;
More informationWarfarin is used to prevent cardioembolism resulting
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage A Longitudinal Population-Based Study Juha Huhtakangas, MD; Sami Tetri, MD, PhD; Seppo Juvela, MD, PhD; Pertti Saloheimo, MD, PhD;
More informationENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
More informationMultiphasic Blood Analysis
Understanding Your Multiphasic Blood Analysis Test Results Mon General thanks you for participating in the multiphasic blood analysis. This test can be an early warning of health problems, including coronary
More informationModern Management of ICH
Modern Management of ICH Bradley A. Gross, MD Assistant Professor, Dept of Neurosurgery, University of Pittsburgh October 2018 ICH Background Assessment & Diagnosis Medical Management Surgical Management
More informationBlood Pressure Management in Acute Ischemic Stroke
Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College
More informationA trial fibrillation (AF) is a common arrhythmia that is
679 PAPER Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke K Kimura, K Minematsu, T Yamaguchi, for the Japan Multicenter Stroke
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationTriglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study
1/5 Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study Jennifer S. Lee, Po-Yin Chang, Ying Zhang, Jorge
More informationThrombolysis administration
Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-25 U/L 10-35 U/L 10-30 U/L 10-25 U/L 10-30 U/L 10-35 U/L 10-25 U/L 10-35 U/L 10-25 U/L 10-20 U/L 10-35 U/L Albumin 0-6
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-30 U/L 10-30 U/L 10-20 U/L Albumin 0-6 days 6 days - 37 months 37 months - 7 years 7-20 years 2.6-3.6 g/dl 3.4-4.2 g/dl
More informationCorrelation between Intracerebral Hemorrhage Score and surgical outcome of spontaneous intracerebral hemorrhage
Bangladesh Med Res Counc Bull 23; 39: -5 Correlation between Intracerebral Hemorrhage Score and surgical outcome of spontaneous intracerebral hemorrhage Rashid HU, Amin R, Rahman A, Islam MR, Hossain M,
More informationSupplemental Figures and Legends
Supplemental Figures and Legends Online Figure 1. 18 year old female with SLE and acute homonymous hemianopsia, confusional state, and cognitive dysfunction. A. This TEE four chamber view demonstrates
More informationThe relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan
Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki
More informationDecreased Perihematomal Edema in Thrombolysis-Related Intracerebral Hemorrhage Compared With Spontaneous Intracerebral Hemorrhage
Decreased Perihematomal Edema in Thrombolysis-Related Intracerebral Hemorrhage Compared With Spontaneous Intracerebral Hemorrhage James M. Gebel, MD; Thomas G. Brott, MD; Cathy A. Sila, MD; Thomas A. Tomsick,
More informationProfiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome
Profiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome Heidi Sucharew, PhD; Jane Khoury, PhD; Charles J. Moomaw, PhD; Kathleen Alwell, BSN; Brett M. Kissela,
More informationStudy on Clinical Outcome in Cases of Hypertensive Hemorrhagic Stroke In Relation To Size and Site of The Hemorrhage.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-853, p-issn: 2279-861.Volume 17, Issue 3 Ver.16 March. (18), PP -67 www.iosrjournals.org Study on Clinical Outcome in Cases of Hypertensive
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Serra AL, Poster D, Kistler AD, et al. Sirolimus and kidney
More informationPrimary Prevention of Stroke
Primary Prevention of Stroke Dr Chris Ellis Cardiologist Green Lane CVS Service, Auckland City Hospital & Auckland Heart Group, Mercy Hospital, Auckland 67 Pages Long, 735 References 29 Sub-Headings for
More informationAspirin Resistance in Patients with Chronic Renal Failure (P 5325)
Aspirin Resistance in Patients with Chronic Renal Failure (P 5325) Beste Ozben Sadic 1, Azra Tanrikulu 1, Mehmet Koc 2, Tomris Ozben 3, Oguz Caymaz 1 1 Marmara University, Faculty of Medicine, Department
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,
More informationEmergency Treatment of Ischemic Stroke
Emergency Treatment of Ischemic Stroke JEFFREY BOYLE, M.D., PHD CLINICAL DIRECTOR OF STROKE AT AVERA MCKENNAN AVERA MEDICAL GROUP NEUROLOGY SIOUX FALLS, SD Conflicts of Interest None I will discuss therapies
More informationWCHQ MEASURES AT A GLANCE
WCHQ Ambulatory Measures A1C Blood Sugar Testing A1C Blood Sugar Control Patients with diabetes Patients with diabetes office visit in. Gestational Diabetes (code 648.8) is office visit in. Compliance
More informationGiuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia
Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia Charidimou et al, 2012 Pathogenesis of spontaneous and anticoagulationassociated
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More information